http://stage-webapp.ihtc.org/manual-category/antiplatelet-agents-reversal/ http://stage-webapp.ihtc.org/manual-category/antiplatelet-agents/ http://stage-webapp.ihtc.org/manual-category/antiplatelet-agents-oral-anticoagulants/ 2025-12-08T19:54:43+00:00 http://stage-webapp.ihtc.org/manual-category/antithrombotics-pharmacology-dosing/ http://stage-webapp.ihtc.org/manual-category/appendix/ 2025-10-09T12:56:53+00:00 http://stage-webapp.ihtc.org/manual-category/appendix-a-anticoagulant-conversion-table/ 2025-09-18T13:44:07+00:00 http://stage-webapp.ihtc.org/manual-category/appendix-b-adverse-effects-of-antithrombotic-agents/ http://stage-webapp.ihtc.org/manual-category/appendix-c-adverse-effects-of-reversal-agents/ 2025-09-18T14:31:42+00:00 http://stage-webapp.ihtc.org/manual-category/cox-inhibitors/ 2026-01-21T19:04:38+00:00 http://stage-webapp.ihtc.org/manual-category/cox-inhibitors-appendix-b-adverse-effects-of-antithrombotic-agents/ 2025-09-19T08:39:49+00:00 http://stage-webapp.ihtc.org/manual-category/direct-thrombin-inhibitor/ 2026-01-21T19:18:14+00:00 http://stage-webapp.ihtc.org/manual-category/direct-thrombin-inhibitor-oral-anticoagulants/ 2025-12-08T19:59:22+00:00 http://stage-webapp.ihtc.org/manual-category/direct-thrombin-inhibitors-parenteral-anticoagulants-reversal/ 2025-09-19T13:01:09+00:00 http://stage-webapp.ihtc.org/manual-category/direct-thrombin-inhibitors/ 2026-01-21T19:13:29+00:00 http://stage-webapp.ihtc.org/manual-category/direct-thrombin-inhibitors-appendix-b-adverse-effects-of-antithrombotic-agents/ 2025-09-19T08:34:24+00:00 http://stage-webapp.ihtc.org/manual-category/factor-xa-inhibitors-oral-anticoagulants/ 2025-12-08T21:00:06+00:00 http://stage-webapp.ihtc.org/manual-category/factor-xa-inhibitors-appendix-b-adverse-effects-of-antithrombotic-agents/ 2025-09-19T08:27:28+00:00 http://stage-webapp.ihtc.org/manual-category/factor-xa-inhibitors/ 2026-01-21T19:34:27+00:00 http://stage-webapp.ihtc.org/manual-category/fibrinolytic-agents/ 2025-12-02T22:47:46+00:00 http://stage-webapp.ihtc.org/manual-category/fibrinolytic-agents-reversal/ 2025-12-02T22:59:24+00:00 http://stage-webapp.ihtc.org/manual-category/glycoprotein-iib-iiia-receptor-antagonists/ 2025-12-02T23:34:58+00:00 http://stage-webapp.ihtc.org/manual-category/glycoprotein-iib-iiia-receptor-antagonists-appendix-b-adverse-effects-of-antithrombotic-agents/ 2025-09-19T09:18:38+00:00 http://stage-webapp.ihtc.org/manual-category/glycoprotein-ilb-illa-receptor-antagonists/ 2025-12-16T17:54:35+00:00 http://stage-webapp.ihtc.org/manual-category/hemostatic-antithrombotic-reversal-agents/ 2025-10-09T06:58:18+00:00 http://stage-webapp.ihtc.org/manual-category/heparin-derivatives/ 2026-01-21T19:37:10+00:00 http://stage-webapp.ihtc.org/manual-category/heparin-derivatives-parenteral-anticoagulants-reversal/ 2025-08-23T10:25:13+00:00 http://stage-webapp.ihtc.org/manual-category/heparin-derivatives-appendix-b-adverse-effects-of-antithrombotic-agents/ 2025-09-19T08:03:20+00:00 http://stage-webapp.ihtc.org/manual-category/introduction/ 2025-12-02T23:25:31+00:00 http://stage-webapp.ihtc.org/manual-category/low-molecular-weight-heparins/ 2025-12-08T20:45:53+00:00 http://stage-webapp.ihtc.org/manual-category/non-heparinoid-xa-inhibitors-appendix-b-adverse-effects-of-antithrombotic-agents/ 2025-08-23T09:47:23+00:00 http://stage-webapp.ihtc.org/manual-category/non-heparinoid-xa-inhibitors-parenteral-anticoagulants-reversal/ 2025-08-23T10:27:11+00:00 http://stage-webapp.ihtc.org/manual-category/non-heparinoid-xa-inhibitors/ 2026-01-21T19:27:51+00:00 http://stage-webapp.ihtc.org/manual-category/oral-anticoagulants/ http://stage-webapp.ihtc.org/manual-category/oral-anticoagulant/ http://stage-webapp.ihtc.org/manual-category/par-1-antagonist/ 2025-12-02T23:39:49+00:00 http://stage-webapp.ihtc.org/manual-category/par-1-antagonist-appendix-b-adverse-effects-of-antithrombotic-agents/ 2025-09-19T09:05:28+00:00 http://stage-webapp.ihtc.org/manual-category/par-1-antagonists/ 2025-12-02T23:36:08+00:00 http://stage-webapp.ihtc.org/manual-category/parenteral-anticoagulants-reversal/ http://stage-webapp.ihtc.org/manual-category/parenteral-anticoagulants/ http://stage-webapp.ihtc.org/manual-category/phosphodiesterase-inhibitors/ 2025-12-08T21:02:42+00:00 http://stage-webapp.ihtc.org/manual-category/phosphodiesterase-inhibitors-appendix-b-adverse-effects-of-antithrombotic-agents/ 2025-09-19T08:46:15+00:00 http://stage-webapp.ihtc.org/manual-category/phosphodiesterase-inhibitors-antiplatelet-agents-reversal/ 2025-12-08T21:06:06+00:00 http://stage-webapp.ihtc.org/manual-category/preface-grades-of-evidence/ 2025-10-03T09:39:46+00:00 http://stage-webapp.ihtc.org/manual-category/reversal/ 2025-10-09T06:29:30+00:00 http://stage-webapp.ihtc.org/manual-category/thienopyridines-appendix-b-adverse-effects-of-antithrombotic-agents/ 2025-09-19T08:59:16+00:00 http://stage-webapp.ihtc.org/manual-category/thienopyridines/ 2025-12-08T21:05:35+00:00 http://stage-webapp.ihtc.org/manual-category/vitamin-k-antagonist-appendix-b-adverse-effects-of-antithrombotic-agents/ 2025-08-23T11:04:18+00:00 http://stage-webapp.ihtc.org/manual-category/vitamin-k-antagonist-oral-anticoagulants/ 2025-12-08T21:12:08+00:00 http://stage-webapp.ihtc.org/manual-category/vitamin-k-antagonist/ 2026-01-21T19:38:28+00:00